ArticleJournal of physiological anthropology2017
Anthropometric and metabolic indices in assessment of type and severity of dyslipidemia.
Article in Journal of physiological anthropology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Gender-Specific Predictive Utility of Twelve Anthropometric Indices for Metabolic Syndrome in Chinese Lahu Adults with Dyslipidemia.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- Predictive value of anthropometric indices for incident of dyslipidemia: a large population-based study.Population health metrics · 2025Article
- Exploring inflammation and adipose tissue dysfunction in metabolically healthy versus unhealthy obesity among Arab adults.Diabetology & metabolic syndrome · 2025Article
- Association ofGenes · 2025Observational
- Elevated body roundness index increases the risk of cardiovascular disease in Chinese patients with circadian syndrome.Frontiers in endocrinology · 2025Article
- Association Between Novel Lipid and Anthropometric Indices and Sleep Duration and Disturbance: A Cross-Sectional NHANES Study 2005-2020.International journal of endocrinology · 2025Article
- Prevalence of dyslipidemia and predictive value of anthropometric indicators among children and adolescents in the Tibetan Plateau.Frontiers in nutrition · 2025Article
- Predicting the 10-year incidence of dyslipidemia based on novel anthropometric indices, using data mining.Lipids in health and disease · 2024Article
- The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome.Frontiers in endocrinology · 2024Article
- Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy.Frontiers in pharmacology · 2024Article
- Development and validation of a simple-to-use nomogram for self-screening the risk of dyslipidemia.Scientific reports · 2023Article
- Atherogenic dyslipidemia and associated risk factors among hypertensive patients of five health facilities in Northeast Ethiopia.PloS one · 2023Article
- Relationship between anthropometric indices and Mizaj (temperament) in Persian medicine.Caspian journal of internal medicine · 2023Article
- The association of a body shape index and visceral adiposity index with neurotrophic, hormonal and metabolic factors among apparently healthy women: a cross-sectional analysis.Journal of diabetes and metabolic disorders · 2022Article
- Factors associated with dyslipidemia and its prevalence among Awash wine factory employees, Addis Ababa, Ethiopia: a cross-sectional study.BMC cardiovascular disorders · 2022Article
- Development and validation of a carotid atherosclerosis risk prediction model based on a Chinese population.Frontiers in cardiovascular medicine · 2022Article
- Novel and traditional anthropometric indices for identifying metabolic syndrome in non-overweight/obese adults.Nutrition & metabolism · 2021Article
- Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Article
- The Usefulness of Anthropometric Indices to Identify the Risk of Metabolic Syndrome.Nutrients · 2019Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt has been shown that obesity is associated with increased rates of dyslipidemia. The present work revisits the association between plasma lipid levels and classical indicators of obesity including body mass index (BMI). The significance of various anthropometric/metabolic variables in clinical assessment of type and severity of dyslipidemia was also determined. Recently described body indices, a body shape index (ABSI) and body roundness index (BRI), were also assessed in this context.
methodsFor the present cross-sectional analytical study, the participants (n = 275) were recruited from the patients visiting different health camps. Participants were anthropometrically measured and interviewed, and their fasting intravenous blood was collected. Plasma lipid levels were accordingly determined.
resultsThe values for different anthropometric parameters are significantly different between dyslipidemic and non-dyslipidemic participants. Receiver operating characteristics curve analyses revealed that all the tested variables gave the highest area under the curve (AUC) values for predicting hypertriglyceridemia in comparison to other plasma lipid abnormalities. BRI gave slightly higher AUC values in predicting different forms of dyslipidemia in comparison to BMI, whereas ABSI gave very low values.
conclusionsSeveral anthropometric/metabolic indices display increased predictive capabilities for detecting hypertriglyceridemia in comparison to any other form of plasma lipid disorders. The capacity of BRI to predict dyslipidemia was comparable but not superior to the classical indicators of obesity, whereas ABSI could not detect dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.